Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial-Reference-Cited by-同舟云学术

Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial

Published:2013-03-08 Issue:2 Volume:138 Page:499-508
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Bjarnadottir Olöf,Romero Quinci,Bendahl Pär-Ola,Jirström Karin,Rydén Lisa,Loman Niklas,Uhlén Mathias,Johannesson Henrik,Rose Carsten,Grabau Dorthe,Borgquist Signe

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-013-2473-6.pdf

Reference47 articles.

1. Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sorensen HT, Lash TL (2011) Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst 103:1461–1468. doi: 10.1093/jnci/djr291

2. Bennis F, Favre G, Le Gaillard F, Soula G (1993) Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549. Int J Cancer 55:640–645

3. Bonovas S, Filioussi K, Tsavaris N, Sitaras NM (2005) Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies. J Clin Oncol 23:8606–8612

4. Borgquist S, Djerbi S, Ponten F, Anagnostaki L, Goldman M, Gaber A, Manjer J, Landberg G, Jirstrom K (2008) HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors. Int J Cancer 123:1146–1153

5. Borgquist S, Jogi A, Ponten F, Ryden L, Brennan DJ, Jirstrom K (2008) Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer. Breast Cancer Res 10:R79. doi: bcr214610.1186/bcr2146

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Statins on Markers of Breast Cancer Proliferation and Apoptosis in Women with In Situ or Early-Stage Invasive Breast Cancer;International Journal of Molecular Sciences;2024-09-04

2. NR0B2 re-educates myeloid immune cells to reduce regulatory T cell expansion and progression of breast and other solid tumors;Cancer Letters;2024-08

3. Optimization of atorvastatin and quercetin-loaded solid lipid nanoparticles using Box-Behnken design;Nanomedicine;2024-07-14

4. Statins inhibit paclitaxel-induced PD-L1 expression and increase CD8+ T cytotoxicity for better prognosis in breast cancer;International Journal of Surgery;2024-05-13

5. Causal association between lipid-lowering drugs and cancers: A drug target Mendelian randomization study;Medicine;2024-05-03